[1] CHEN WQ,ZHENG RS,BAADE PD,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115-132.
|
[2] BULTEAUAL,SZWEDA LI,FRIGUET B. Mitochondrial protein oxidation and degradation in response to oxidative stress and aging[J]. Exp Gerontol,2006,41(7):653-657.
|
[3] TATSUTA T. Protein quality control in mitochondria[J]. J Biochem,2009,146(4):455-461.
|
[4] GIBELLINI L,LOSI L,de BIASI S,et al. LONP1 differently modulates mitochondrial function and bioenergetics of primary versus metastatic colon cancer cells[J]. Front Oncol,2018,8:254.
|
[5] NIE XB,LI M,LU B,et al. Down-regulating overexpressed human lon in cervical cancer suppresses cell proliferation and bioenergetics[J]. PLo S One,2013,8(11):e81084.
|
[6] LIU Y,LAN L,HUANG K,et al. Inhibition of Lon blocks cell proliferatiaon,enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer:potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer[J]. Oncotarget,2014,5(22):11209-11224.
|
[7] National Health and Family Planning Commission of the People’s Repubilc of China. Diagnosis,management,and treatment of hepatocellular carcinoma(V2017)[J]. J Clin Hepatol,2017,33(8):1419-1431.(in Chinese)中华人民共和国国家卫生和计划生育委员会.原发性肝癌诊疗规范(2017年版)[J].临床肝胆病杂志,2017,33(8):1419-1431.
|
[8] Chinese Society of Liver Cancer,Chinese Anti-Cancer Association; Liver Cancer Study Group,Chinese Society of Pathology,Chinese Medical Association; Chinese Society of Pathology,Chinese Anti-Cancer Association,et al. Standardized pathological diagnosis guidelines for primary liver cancer(2015)[J]. J Clin Hepatol,2015,31(6):833-839.(in Chinese)中国抗癌协会肝癌专业委员会,中华医学会肝病学分会肝癌学组,中国抗癌协会病理专业委员会,等.原发性肝癌规范化病理诊断指南(2015年版)[J].临床肝胆病杂志,2015,31(6):833-839.
|
[9] WANG YP,TANG DX. Expression of Yes-associated protein in liver cancer and its correlation with clinicopathological features and prognosis of liver cancer patients[J]. Int J Clin Exp Med,2015,8(1):1080-1086.
|
[10] CHENG CW,KUO CY,FAN CC,et al. Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species[J]. Cell Death Dis,2013,4:e681.
|
[11] GIBELLINI L,PINTI M,BORALDI F,et al. Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells[J]. FASEB J,2014,28(12):5122-5135.
|
[12] GILLIES RJ,GATENBY RA. Adaptive landscapes and emergent phenotypes:Why do cancers have high glycolysis?[J].J Bioenerg Biomembr,2007,39(3):251-257.
|
[13] BULTEAU AL,BAYOT A. Mitochondrial proteases and cancer[J]. Biochim Biophys Acta,2011,1807(6):595-601.
|